Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991016923) NOVEL SYNTHETIC GRF ANALOGS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/016923 International Application No.: PCT/US1991/003053
Publication Date: 14.11.1991 International Filing Date: 30.04.1991
Chapter 2 Demand Filed: 26.11.1991
IPC:
A61K 38/00 (2006.01) ,C07K 14/60 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
575
Hormones
60
Growth hormone-releasing factor (GH-RF) (Somatoliberin)
Applicants:
THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND [US/US]; Tulane University New Orleans, LA 70118, US
Inventors:
COY, David, H.; US
MURPHY, William; US
HOCART, Simon, J.; US
Agent:
OLSON, Arne, M. ; Olson & Hierl 20 N. Wacker Drive Suite 3000 Chicago, IL 60606, US
Priority Data:
519,05404.05.1990US
Title (EN) NOVEL SYNTHETIC GRF ANALOGS
(FR) NOUVEAUX ANALOGUES GRF SYNTHETIQUES
Abstract:
(EN) The present invention relates to novel peptides having therapeutic utility. More specifically, the invention relates to peptide analogs of the naturally occuring peptide, growth hormone-releasing factor (GRF). The invention also relates to therapeutic compositions containing these peptides, and therapeutic methods using these peptides to stimulate the productioin of growth hormone $i(in vivo).
(FR) L'invention concerne de nouveaux peptides ayant une utilisation thérapeutique. Plus spécifiquement, l'invention concerne des analogues peptidiques du facteur de libération d'hormone de croissance (GRF) de peptides se produisant naturellement. L'invention concerne également des compositions thérapeutiques contenant ces peptides, et des procédés thérapeutiques utilisant ces peptides pour stimuler la production de l'hormone de croissance $i(in vivo).
Designated States: AU, CA, JP
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0527914JPH06502618CA2082059AU1991078822